Hongene Biotech Corporation

Hongene Biotech Corporation is a manufacturer with state-of-the-art facilities in the fields of nucleosides, nucleotides, and phosphoramidites. Founded in 2018, the company is a global specialist in nucleic acid raw material supply and CDMO services, operating from its headquarters in the United States.

Committed to providing high-quality, high-value products with best-in-class lead times, Hongene is dedicated to the universal accessibility of nucleic acid medicines. Leveraging its world-renowned expertise and specialized capabilities, the company ensures on-time and budget-friendly project delivery, aiming to support the development of life-changing treatments for patients.

With decades of world-class experience, Hongene serves as a trusted partner, offering end-to-end guidance and a vertically integrated supply chain for small-scale synthesis to GMP manufacturing. The company's commitment to innovation, market-leading capacity, and consistently high-quality products positions it as a key player in the Biotechnology, Manufacturing, and Pharmaceutical industries.

Despite the absence of publicly disclosed recent investments and investors, Hongene Biotech Corporation continues to showcase its potential for growth and impact in the highly specialized and ever-evolving biotech and pharmaceutical sectors.